61 research outputs found
Connection of the ABO blood group system from the whole blood groups with the diabetes mellitus typ 2 for the period 2005-2009
Introduction:The real dimension of the connection between any blood group from the ABO system of blood groups and diabetes mellitus typ 2 in the eastern part of Republic of Macedonia in not well known.
Aim:The aim of our study was to establish the connection of the blood group from the ABO system of blood groups with diabetes mellitus typ 2.
Material and methods:The total number of registered patients with diabetes mellitus typ 2 in the Center of diabetes in Clinical hospital in Stip for the period 2005-2009 is 5,342. They were followed belong to ABO system of blood group by the determination of the ABO blood group and after receiving the written permission.The control group contained 12,500 healthy blood donors donated blood during the same period. The examination of the patients was realized in the RE of Transfusion in Stip using micro-agglutinated cards (Dia Med-ID Mikro Typing Systems).
Results:The results using Chi-square test showed no connection between ABO blood groups and diabetes mellitus typ 2. Blood group "A" and "O" were negatively associated with diabetes mellitus typ 2 (P < 0,005) because the biggest part of that blood group were no diabetic patients. There is no significant association between blood group "B" and "AB" with diabetes mellitus typ 2, although most of patients with diabetes mellitus typ 2 were with blood group "B".
Discussion and conclusion:After completed the study, obtained results confirmed that there is a negative correlation of blood group "A" and "O" from the ABO system od blood groups with diabetes mellitus type 2
Analysis of metals in the serum of professionally exposed population of blood-donors from the Buchim-Radovish mine and unexposed general population from the municipality of Shtip
Aims:To determine the concentration of heavy metals in the serum of professionally exposed blood donor population from Buchim-Radovish mine and the unexposed general population (control group) from Shtip. To estimate the potential difference of heavy metals concentration and their impact on the health of blood recipients.
Methods and materials:The concentration of heavy metals (Mn, Cr, Zn, Cu, Pb, Ni, Co, Cd) was analyzed in the serum of 30 professionally exposed miners blood donors from active Buchim mine, located nearby the town of Radovish. The control group comprised of 30 samples from the general population from Shtip, not directly exposed to heavy metals. The research was conducted in the chemical-biochemical laboratory at the University βGoce Delchevβ in Shtip, using the equipment ISP-AES, Liberty 110, Varian.
Results and discussion:Concentrations of Mn, Zn, Cu, Pb were significantly higher in the group of miners compared with the control group. The concentration of Cu correlates significantly with the concentration of Zn. This result is in line with the known fact that Cd, Cu, Zn bond to metallothionein in vivo, while Mn does not. Concentrations of Co and Cd were not significantly different between the analyzed groups, only Ni concentration is higher in the control group. Average values of analyzed metals were higher in the exposed group than in control group as reported in several studies on miners and other professionally exposed workers.
Conclusion:Heavy metals have major impact of human health and environment. Strict legislation aiming to solve raising problems in this area gives vital importance to the monitoring of heavy metals. It is necessary to undertake further detailed analysis on the impact of higher concentrations of heavy metals in the blood of miners blood donors and on the health of blood recipients
ΠΡΠΎΡΠΈΠ»Π°ΠΊΡΠ° Π½Π° Hepatitis B ΠΊΠ°Ρ Π΄Π΅ΡΠ° ΡΠΎΠ΄Π΅Π½ΠΈ ΠΎΠ΄ HBsAg ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΠΈ ΠΌΠ°ΡΠΊΠΈ Π²ΠΎ MΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈ ΡΠ΅Π½ΡΠ°Ρ Π²ΠΎ Π¨ΡΠΈΠΏ
Π¦Π΅Π» Π½Π° ΡΡΡΠ΄ΠΎΡ: ΠΡΠΎΡΠΈΠ»Π°ΠΊΡΠ° Π½Π° Π²Π΅ΡΡΠΈΠΊΠ°Π»Π½Π° ΡΡΠ°Π½ΡΠΌΠΈΡΠΈΡΠ° Π½Π° Hepatitis B.
ΠΠ°ΡΠ΅ΡΠΈΡΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈ: ΠΠ΅ΡΠ°ΡΠ° ΡΠΎΠ΄Π΅Π½ΠΈ ΠΎΠ΄ HBsAg ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΠΈ ΠΌΠ°ΡΠΊΠΈ Π²Π΅Π΄Π½Π°Ρ ΠΏΠΎ ΠΏΠΎΡΠΎΠ΄ΡΠ²Π°ΡΠ΅ΡΠΎ ΡΠ΅ ΡΠ΅ΡΡΠΈΡΠ°Π½ΠΈ Π·Π° ΡΡΠ²ΡΠ΄ΡΠ²Π°ΡΠ΅ ΠΏΡΠΈΡΡΡΡΠ²ΠΎ Π½Π° HBsAg ΡΠΎ ΠΠΈΠΊΡΠΎΠ΅Π»ΠΈΡΠ° ΡΠ΅ΡΡ ΠΎΠ΄ ΡΡΠ΅ΡΠ° Π³Π΅Π½Π΅ΡΠ°ΡΠΈΡΠ° (Organon Teknika). ΠΠ°ΠΊΠΎ ΠΏΠΎΡΠ²ΡΠ΄Π΅Π½ ΡΠ΅ΡΡ Π΅ ΠΊΠΎΡΠΈΡΡΠ΅Π½ Lia Tek HCV (Organon Teknika). ΠΠ°ΡΠ΅Π΄Π½ΠΈΡΠ΅ ΡΠ΅ΡΡΠΈΡΠ°ΡΠ° ΡΠ΅ ΠΈΠ·Π²ΡΡΠ΅Π½ΠΈ ΠΏΡΠ΅Π΄ Π°ΠΏΠ»ΠΈΠΊΠ°ΡΠΈΡΠ° Π½Π° Π²ΡΠΎΡΠ° Π΄ΠΎΠ·Π° HB Π²Π°ΠΊΡΠΈΠ½Π°, ΠΏΠΎΡΠΎΠ° 1 ΠΌΠ΅ΡΠ΅Ρ ΠΏΠΎ Π΄ΠΎΠ±ΠΈΠ²Π°ΡΠ΅ Π½Π° Π²ΡΠΎΡΠ° ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ½Π° Π΄ΠΎΠ·Π°, ΠΏΠΎΡΠΎΠ° ΠΏΡΠ΅Π΄ Π°ΠΏΠ»ΠΈΠΊΠ°ΡΠΈΡΠ° Π½Π° ΡΡΠ΅ΡΠ°ΡΠ° ΠΈ 1, 6 ΠΈ 12 ΠΌΠ΅ΡΠ΅ΡΠΈ ΠΏΠΎ ΡΡΠ΅ΡΠ°ΡΠ° ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ½Π° Π΄ΠΎΠ·Π°. Π‘Π΅ Π΄Π΅ΡΠ΅ΠΊΡΠΈΡΠ°ΡΠ΅ ΠΈ ΠΏΡΠΈΡΡΡΡΠ²ΠΎ Π½Π° Π°Π½ΡΠΈ-HBs (Nubenco Diagnostics, Inc. One Kalisa Way, Paramus, (U.S.A.).
Π Π΅Π·ΡΠ»ΡΠ°ΡΠΈ: ΠΎΠ΄ 1050 ΡΠ΅Π΄ΠΎΠ²Π½ΠΎ ΡΠ΅ΡΡΠΈΡΠ°Π½ΠΈ Π±ΡΠ΅ΠΌΠ΅Π½ΠΈ ΠΆΠ΅Π½ΠΈ ΠΏΡΠΈΡΡΡΡΠ²ΠΎ Π½Π° HBsAg Π΅ ΠΎΡΠΊΡΠΈΠ΅Π½ΠΎ ΠΊΠ°Ρ 14(1,33%). ΠΠ°Ρ Π½ΠΈΡΡ Π΅Π΄Π½Π° ΠΎΠ΄ ΠΈΡΠΏΠΈΡΡΠ²Π°Π½ΠΈΡΠ΅ Π±ΡΠ΅ΠΌΠ΅Π½ΠΈ ΡΠ΅Π½ΠΈ Π½Π΅ Π΅ ΡΠ΅Π³ΠΈΡΡΡΠΈΡΠ°Π½ Π°ΠΊΡΡΠ΅Π½ Ρ
Π΅ΠΏΠ°ΡΠΈΡ, Π½ΠΈΡΡ ΠΏΠΎΡΠ΅ΠΌΠ΅ΡΡΠ²Π°ΡΠ΅ Π½Π° Ρ
Π΅ΠΏΠ°ΡΠ°Π»Π½ΠΈΠΎΡ ΠΈ Π΅Π½Π·ΠΈΠΌΡΠΊΠΈΠΎΡ ΡΡΠ°ΡΡΡΡ. ΠΠ΅Π΄Π½Π°Ρ ΠΏΠΎ ΠΏΠΎΡΠΎΠ΄ΡΠ²Π°ΡΠ΅ΡΠΎ ΡΠΈΡΠ΅ 14 Π½ΠΎΠ²ΠΎΡΠΎΠ΄Π΅Π½ΠΈ Π΄Π΅ΡΠ° ΡΠ΅ ΡΠ΅ΡΡΠΈΡΠ°Π½ΠΈ Π·Π° ΠΏΡΠΈΡΡΡΡΠ²ΠΎ Π½Π° HBsAg. ΠΠ°Ρ Π½ΠΈΡΡ Π΅Π΄Π½ΠΎ Π½Π΅ Π΅ ΠΎΡΠΊΡΠΈΠ΅Π½ΠΎ ΠΏΡΠΈΡΡΡΡΠ²ΠΎ Π½Π° HBsAg..ΠΠΎΡΠ°Π΄ΠΈ ΡΠΎΠ° Π°ΠΏΠ»ΠΈΡΠΈΡΠ°Π½ΠΈ ΡΠ΅ i.m. 0,5 ml ) ENGERIX Π³Π΅Π½Π΅ΡΠΈΡΠΊΠΈ ΠΏΡΠΎΠΈΠ·Π²Π΅Π΄Π΅Π½Π° HB Π²Π°ΠΊΡΠΈΠ½Π°. Π‘Π΅ΡΡΠΌ (HBIG) Π½Π΅ Π°ΠΏΠ»ΠΈΡΠΈΡΠ°Π²ΠΌΠ΅ ΠΏΠΎΡΠ°Π΄ΠΈ Π½Π΅ΠΌΠ°ΡΠ΅ ΠΌΠΎΠΆΠ½ΠΎΡΡ ΠΎΠ΄ Π½Π°Π±Π°Π²ΠΊΠ°. ΠΠ΄Π΅Π½ ΠΌΠ΅ΡΠ΅Ρ ΠΏΠΎ Π°ΠΏΠ»ΠΈΠΊΠ°ΡΠΈΡΠ°ΡΠ° Π½Π° Π²ΡΠΎΡΠ°ΡΠ° Π΄ΠΎΠ·Π° HB Π²Π°ΠΊΡΠΈΠ½Π°, ΠΏΠΎΡΠΎΠ° 1, 6 ΠΈ 12 ΠΌΠ΅ΡΠ΅ΡΠΈ ΠΎΠ΄ Π°ΠΏΠ»ΠΈΠΊΠ°ΡΠΈΡΠ°ΡΠ° Π½Π° ΡΡΠ΅ΡΠ°ΡΠ° Π΄ΠΎΠ·Π° HB Π²Π°ΠΊΡΠΈΠ½Π°, ΡΠ΅ΡΡΠΌΡΠΊΠΈ ΠΏΡΠΈΠΌΠ΅ΡΠΎΡΠΈ ΠΎΠ΄ Π½ΠΎΠ²ΠΎΡΠΎΠ΄Π΅Π½ΠΈΡΠ΅ Π΄Π΅ΡΠ° ΡΠ΅ ΡΠ΅ΡΡΠΈΡΠ°Π½ΠΈ Π·Π° ΠΎΡΠΊΡΠΈΠ²Π°ΡΠ΅ ΠΏΡΠΈΡΡΡΡΠ²ΠΎ Π½Π° HBsAg I anti - HBs.. Testirawata poka\aa negativni rezultati. Kaj Π½ΠΈ Π΅Π΄Π½ΠΎ ΠΎΠ΄ ΠΈΡΠΏΠΈΡΠ°Π½ΠΈΡΠ΅ Π΄Π΅ΡΠ° Π½Π΅ Π΅ ΡΠ΅Π³ΠΈΡΡΠ°Π½ Π°ΠΊΡΡΠ΅Π½ Ρ
Π΅ΠΏΠ°ΡΠΈΡ, Π½ΠΈΡΡ ΠΏΠΎΡΠ΅ΠΌΠ΅ΡΡΠ²Π°ΡΠ΅ Π½Π° Ρ
Π΅ΠΏΠ°ΡΠ°Π»Π½ΠΈΠΎΡ ΠΈ Π΅Π½Π·ΠΈΠΌΡΠΊΠΈΠΎΡ ΡΡΠ°ΡΡΡ.. Π ΠΏΠΎΠΊΡΠ°Ρ Π·Π°Π±ΡΠ°Π½Π°ΡΠ° Π·Π° Π΄ΠΎΠ΅ΡΠ΅ Π΄Π΅Π» ΠΎΠ΄ Π΄Π΅ΡΠ°ΡΠ° ΡΠ΅ Π΄ΠΎΠ΅Π½ΠΈ Π±Π΅Π· Π½Π°ΡΠ° ΡΠΎΠ³Π»Π°ΡΠ½ΠΎΡΡ.
ΠΠ°ΠΊΠ»ΡΡΠΎΠΊ: Π ΠΏΠΎΠΊΡΠ°Ρ ΡΠΎΠ° ΡΡΠΎ Π½Π°ΡΠΈΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΠ°ΡΠΈ ΡΠ΅ ΡΠ°Π·Π»ΠΈΠΊΡΠ²Π°Π°Ρ ΠΎΠ΄ ΠΌΠ½ΠΎΠ³Ρ ΠΏΠΎΠ΄Π°ΡΠΎΡΠΈ Π²ΠΎ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ°ΡΠ° ΡΠΎ ΠΈΡΡΠ° ΠΈΠ»ΠΈ ΡΠ»ΠΈΡΠ½Π° ΡΠ΅Π», ΡΠ΅ΠΏΠ°ΠΊ ΠΏΡΠ΅ΠΏΠΎΡΠ°ΡΡΠ²Π°ΠΌΠ΅ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅Π½ ΡΡΠ΅ΡΠΌΠ°Π½ Π½Π° ΡΠΈΡΠ΅ Π½ΠΎΠ²ΠΎΡΠΎΠ΄Π΅Π½ΠΈ Π΄Π΅ΡΠ° ΠΎΠ΄ HBsAg ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΠΈ ΠΌΠ°ΡΠΊΠΈ ΡΠΎ HBIG I HB Π²Π°ΠΊΡΠΈΠ½Π°, ΠΈ Π·Π°Π±ΡΠ°Π½Π° Π·Π° Π΄ΠΎΠ΅ΡΠ΅
60 Π³ΠΎΠ΄ΠΈΠ½ΠΈ Π‘Π»ΡΠΆΠ±Π° Π·Π° ΡΡΠ°Π½ΡΡΡΠ·ΠΈΡΠ° Π½Π° ΠΊΡΠ², 60 Π³ΠΎΠ΄ΠΈΠ½ΠΈ ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΈΡΠ°Π½ΠΎ ΠΊΡΠ²ΠΎΠ΄Π°ΡΡΠ²Π°ΡΠ΅ Π²ΠΎ ΠΎΠΏΡΡΠΈΠ½Π° Π¨ΡΠΈΠΏ
Π‘ΡΠ°Π½ΡΠ²Π° Π·Π±ΠΎΡ Π·Π° ΡΠ΅ΡΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½Π° ΡΡΡΠ΄ΠΈΡΠ° ΠΊΠΎΡΠ° Π³ΠΎ ΠΏΡΠΈΠΊΠ°ΠΆΡΠ²Π° ΡΠ°Π·Π²ΠΎΡΠΎΡ Π½Π° ΠΊΡΠ²ΠΎΠ΄Π°ΡΠΈΡΠ΅Π»ΡΡΠ²ΠΎΡΠΎ Π²ΠΎ ΠΎΠΏΡΡΠΈΠ½Π° Π¨ΡΠΈΠΏ, Π²ΠΎ ΠΏΠ΅ΡΠΈΠΎΠ΄ΠΎΡ ΠΎΠ΄ 50 Π³ΠΎΠ΄ΠΈΠ½ΠΈ ΠΎΠ΄ ΠΌΠΈΠ½Π°ΡΠΈΠΎΡ Π²Π΅ΠΊ ΠΏΠ° ΡΠ΅ Π΄ΠΎ Π΄Π΅Π½Π΅Ρ.
ΠΠ΅Π³ΠΎΠ²ΠΈΡΠ΅ ΠΏΠΎΡΠ΅ΡΠΎΡΠΈ, ΠΏΡΠΎΠΌΠ΅Π½ΠΈ, Π½Π΅Π΄ΠΎΡΠ»Π΅Π΄Π½ΠΎΡΡΠΈ ΠΈ ΠΏΡΠΈΠ»Π°Π³ΠΎΠ΄ΡΠ²Π°ΡΠ° ΠΊΠΎΠ½ ΡΠ΅Π»ΠΎΠΊΡΠΏΠ½ΠΈΠΎΡ Π·Π΄ΡΠ°Π²ΡΡΠ²Π΅Π½ ΡΠΈΡΡΠ΅ΠΌ.
Π¦Π΅Π»ΠΎΠΊΡΠΏΠ½Π°ΡΠ° ΡΡΡΠ΄ΠΈΡΠ° Π΅ Π±Π°Π·ΠΈΡΠ°Π½Π° Π½Π° ΡΠΈΡΠ΅ Π΄ΠΎΡΠ΅Π³Π°ΡΠ½ΠΈ Π°ΡΡ
ΠΈΠ²ΡΠΊΠΈ ΠΏΠΎΠ΄Π°ΡΠΎΡΠΈ ΠΎΠ΄ ΠΠ»ΠΈΠ½ΠΈΡΠΊΠ°ΡΠ° Π±ΠΎΠ»Π½ΠΈΡΠ° Π²ΠΎ Π¨ΡΠΈΠΏ ΠΈ ΠΏΠΎΡΠΈΡΠΎΠΊΠΎ
Prevention of transfusion transmissive bacterial infection in working unit Transfusiology in the Medical Center in Stip
Measures to be shown for prevention and reduction of bacterial contamination of donated blood and bacteriological procedures which are appled in WU Transfusiology for prevention of bacterial infection through blood and components
Therapy with depleted erythrocyte concentrates and the occurrence of post-transfusion reactions with patients treated from bone marrow insufficiency at the daily blood transfusion hospital in Stip
Aim: To present the number and adverse post-transfusion reactions with patients suffering from bone marrow insufficiency, with transfunded depleted erythrocyte concentrates
ΠΠΎΡΡΠΈΠ³Π½Π°ΡΠΈ ΡΠ΅Π·ΡΠ»ΡΠ°ΡΠΈ Π½Π° ΠΏΠΎΠ»Π΅ΡΠΎ Π½Π° ΠΊΡΠ²ΠΎΠ΄Π°ΡΠΈΡΠ΅Π»ΡΡΠ²ΠΎΡΠΎ Π²ΠΎ ΠΎΠΏΡΡΠΈΠ½Π° Π¨ΡΠΈΠΏ Π·Π° ΠΏΠ΅ΡΠΈΠΎΠ΄ΠΎΡ 1979-1988 Π³ΠΎΠ΄ΠΈΠ½Π°
ΠΠ΅ΡΠ΅Ρ Π³ΠΎΠ΄ΠΈΡΠ½ΠΈΡΠ΅ Π½Π°ΠΏΠΎΡΠΈ Π½Π° Π Π ΡΡΠ°Π½ΡΡΡΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ°, ΠΠΏΡΠΈΠ½ΡΠΊΠΈΠΎΡ Π¦ΡΠ²Π΅Π½ ΠΊΡΡΡ ΠΈ ΡΠΈΡΠ΅ ΠΏΠΎΡΠΏΠΈΡΠ½ΠΈΡΠΈ Π½Π° ΠΠΏΡΡΠ΅ΡΡΠ²Π΅Π½ΠΈΠΎΡ Π΄ΠΎΠ³ΠΎΠ²ΠΎΡ Π·Π° ΡΠ½Π°ΠΏΡΠ΅Π΄ΡΠ²Π°ΡΠ΅ Π½Π° ΠΊΡΠ²ΠΎΠ΄Π°ΡΠΈΡΠ΅Π»ΡΡΠ²ΠΎΡΠΎ, ΠΎΠ²ΠΎΠ·ΠΌΠΎΠΆΠΈΡΠ° ΡΠ΅Π»ΠΎΡΠ½ΠΎ ΠΏΠΎΠΊΡΠΈΠ²Π°ΡΠ΅ Π½Π° ΠΏΠΎΡΡΠ΅Π±ΠΈΡΠ΅ ΠΎΠ΄ ΡΠ²Π΅ΡΠ° ΠΊΡΠ² Π²ΠΎ ΡΠ°Π±ΠΎΡΠ½ΠΈΡΠ΅ Π΅Π΄ΠΈΠ½ΠΈΡΠΈ Π½Π° Π Π ΠΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈ ΡΠ΅Π½ΡΠ°Ρ Π¨ΡΠΈΠΏ.
ΠΠΎ ΠΈΠ·ΠΌΠΈΠ½Π°ΡΠΈΡΠ΅ 10 Π³ΠΎΠ΄ΠΈΠ½ΠΈ ΠΏΠ»Π°Π½ΠΈΡΠ°Π½ΠΈ ΡΠ΅ Π²ΠΊΡΠΏΠ½ΠΎ 15.626 ΠΊΡΠ²ΠΎΠ΄Π°ΡΡΠ²Π°ΡΠ°. Π‘ΠΎΠ±ΡΠ°Π½ΠΈ ΡΠ΅ Π²ΠΊΡΠΏΠ½ΠΎ 23.414 ΡΠΈΡΠΈΡΠ° ΠΊΡΠ². ΠΠ»Π°Π½ΠΎΡ Π΅ ΠΈΡΠΏΠΎΠ»Π½Π΅Ρ ΡΠΎ 149,8%.
ΠΠΎ ΠΎΠ²ΠΎΡ ΡΡΡΠ΄ ΡΠ΅ ΠΏΡΠΈΠΊΠ°ΠΆΠ°Π½ΠΈ ΡΠ΅Π·ΡΠ»ΡΠ°ΡΠΈΡΠ΅ Π²ΠΎ ΠΏΠ΅ΡΠΈΠΎΠ΄ ΠΎΠ΄ 1979-1988 Π³ΠΎΠ΄ΠΈΠ½Π° ΠΏΠΎ Π³ΠΎΠ΄ΠΈΠ½ΠΈ, Π·Π°ΡΡΠ°ΠΏΠ΅Π½ΠΎΡΡ ΠΏΠΎ Π²ΠΎΠ·ΡΠ°ΡΡ ΠΈ ΠΏΠΎΠ», Π΄Π°ΡΡΠ²Π°ΡΠ° ΠΏΠΎ ΠΏΡΠ² ΠΏΠ°Ρ ΠΈ ΠΏΠΎΠ²Π΅ΡΠ΅ ΠΏΠ°ΡΠΈ, ΠΊΠ°ΠΊΠΎ ΠΈ ΡΠΎΡΠΈΡΠ°Π»Π½Π°ΡΠ° ΡΡΡΡΠΊΡΡΡΠ° Π½Π° ΠΊΡΠ²ΠΎΠ΄Π°ΡΠΈΡΠ΅Π»ΠΈΡΠ΅
ΠΡΠΏΠΈΡΡΠ²Π°ΡΠ΅ ΠΏΡΠΈΡΡΡΡΠ²ΠΎ Π½Π° Π°Π½ΡΠΈ-Π₯ΠΠ Π°Π½ΡΠΈΡΠ΅Π»Π° Π²ΠΎ ΡΠ΅ΡΡΠΌ ΠΎΠ΄ Π΄ΠΎΠ±ΡΠΎΠ²ΠΎΠ»Π½ΠΈ Π΄Π°ΡΠΈΡΠ΅Π»ΠΈ Π½Π° ΠΊΡΠ² ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ ΠΎΠ΄ Π½Π΅ΠΊΠΎΠ»ΠΊΡ ΡΠΈΠ·ΠΈΡΠ½ΠΈ Π³ΡΡΠΏΠΈ
ΠΠΎ ΠΏΠ΅ΡΠΈΠΎΠ΄ ΠΎΠ΄ 12.05.1988 Π΄ΠΎ 31.01.1989 Π³ΠΎΠ΄ΠΈΠ½Π° Π²ΠΎ Π Π Π’ΡΠ°Π½ΡΡΡΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ° ΠΈΡΠΏΠΈΡΠ°Π½ΠΎ Π΅ ΠΏΡΠΈΡΡΡΡΠ²ΠΎ Π½Π° Π°Π½ΡΠΈ-Π₯ΠΠ Π°Π½ΡΠΈΡΠ΅Π»Π° ΠΊΠ°Ρ 3.124 ΠΊΡΠ²ΠΎΠ΄Π°ΡΠΈΡΠ΅Π»ΠΈ, 34 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ ΡΠΎ Ρ
ΡΠΎΠ½ΠΈΡΠ½Π° Π±ΡΠ±ΡΠ΅ΠΆΠ½Π° ΠΈΠ½ΡΡΡΠΈΡΠΈΠ΅Π½ΡΠΈΡΠ°, 3 Ρ
Π΅ΠΌΠΎΡΠΈΠ»ΠΈΡΠ°ΡΠΈ ΠΈ 7 Π°Π½Π°ΠΌΠ½Π΅ΡΡΠΈΡΠΊΠΈ ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠΊΠΈ ΡΡΡΠΏΠ΅ΠΊΡΠ½ΠΈ ΡΠ»ΡΡΠ°ΠΈ. ΠΠ΄ Π²ΠΊΡΠΏΠ½ΠΎ 3.168 ΠΈΡΠΏΠΈΡΠ°Π½ΠΈ Π½Π°ΡΠ΄Π΅Π½ Π΅ Π΅Π΄Π΅Π½ ΡΠ΅ΡΠΎΠΏΠΎΠ·ΠΈΡΠΈΠ²Π΅Π½ ΠΊΠΎΡ ΠΏΡΠΈΠΏΠ°ΡΠ° Π½Π° ΡΠ°Π·Π»ΠΈΡΠ½Π°ΡΠ° Π³ΡΡΠΏΠ°
Π‘ΠΠΠ - ΡΠΈΡΠ΅ Π·Π°Π΅Π΄Π½ΠΎ ΡΠ΅ ΡΠ° ΠΏΠΎΠ±Π΅Π΄ΠΈΠΌΠ΅
ΠΠΎΠ·Π½Π°ΡΠ° Π΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ²Π½Π°ΡΠ° ΠΏΡΠΈΡΠΎΠ΄Π° Π½Π° Π±ΠΎΠ»Π΅ΡΡΠ°, ΠΏΠ°ΡΠΈΡΡΠ°ΡΠ° Π½Π° ΡΠΈΡΠ΅ΡΠ΅, ΠΏΡΠ΅Π΄ΠΈΠ·Π²ΠΈΠΊΡΠ²Π°ΡΠΎΡ ΠΈ Π½Π΅Π³ΠΎΠ²ΠΈΡΠ΅ ΠΊΠ°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ, ΠΏΠΎΠ·Π½Π°ΡΠΈ ΡΠ΅ ΠΌΠ΅ΡΠΊΠΈΡΠ΅ Π·Π° Π·Π°ΡΡΠΈΡΠ°. Π‘Π΅ΡΠΎ ΡΠΎΠ° ΠΏΡΠ΅ΡΡΡΠ°Π²ΡΠ²Π° Π΅Π΄Π½Π° Π΄ΠΎΠ±ΡΠ° ΠΎΡΠ½ΠΎΠ²Π° ΡΠΎ ΠΊΠΎΡΠ° ΠΌΠΎΠΆΠ΅ Π±Π°ΡΠ΅ΠΌ Π΄Π° ΡΠ΅ Π·Π°ΠΏΡΠ΅ ΠΏΠΎΠ½Π°ΡΠ°ΠΌΠΎΡΠ½Π°ΡΠ° ΡΡΠ°Π½ΡΠΌΠΈΡΠΈΡΠ° Π½Π° Π₯ΠΠ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡΠ°ΡΠ°. ΠΠΎ ΠΎΠ²Π°Π° Π°ΠΊΡΠΈΡΠ° ΡΡΠ΅Π±Π° Π΄Π° ΡΡΠ΅ΡΡΠ²ΡΠ²Π° ΡΠ΅ΠΊΠΎΡ ΠΏΠΎΠ΅Π΄ΠΈΠ½Π΅Ρ, Π½ΠΎ Π³Π»Π°Π²Π½ΠΈΠΎΡ ΠΈ ΠΏΡΠΈΠΌΠ°ΡΠ΅Π½ ΡΠΎΠ²Π°Ρ, ΡΠ΅ΠΏΠ°ΠΊ, ΠΏΠ°ΡΠ° Π½Π° Π·Π΄ΡΠ°Π²ΡΡΠ²Π΅Π½ΠΈΡΠ΅ ΡΠ°Π±ΠΎΡΠ½ΠΈΡΠΈ, Π²ΠΎ ΠΏΡΠ² ΡΠ΅Π΄ Π½Π° Π»Π΅ΠΊΠ°ΡΠΈΡΠ΅
ΠΠ°ΡΡΠ΅ΡΡΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΈ Π±ΠΎΠ»Π΅ΡΡΠΈ Π²ΠΎ Π Π΅ΠΏΡΠ±Π»ΠΈΠΊΠ° ΠΠ°ΠΊΠ΅Π΄ΠΎΠ½ΠΈΡΠ°
ΠΠ½ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΈΡΠ΅ Π±ΠΎΠ»Π΅ΡΡΠΈ ΡΠ΅ Π·Π°Π±ΠΎΠ»ΡΠ²Π°ΡΠ° ΠΊΠΎΠΈ ΡΠ΅ ΠΏΡΠ΅Π΄ΠΈΠ·Π²ΠΈΠΊΠ°Π½ΠΈ ΠΎΠ΄ ΠΏΠ°ΡΠΎΠ³Π΅Π½ΠΈ ΠΌΠΈΠΊΡΠΎΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠΈ - Π±Π°ΠΊΡΠ΅ΡΠΈΠΈ, Π²ΠΈΡΡΡΠΈ, ΠΏΠ°ΡΠ°Π·ΠΈΡΠΈ, Π³Π°Π±ΠΈΡΠΊΠΈ ΠΈ ΡΠ». Π‘Π΅ ΠΏΡΠ΅Π½Π΅ΡΡΠ²Π°Π°Ρ ΠΎΠ΄ ΠΈΠ½ΡΠΈΡΠΈΡΠ°Π½ ΡΠΎΠ²Π΅ΠΊ ΠΈΠ»ΠΈ ΠΆΠΈΠ²ΠΎΡΠ½ΠΎ Π·Π° Π·Π΄ΡΠ°Π² ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΠΌ ΠΈ ΠΈΠΌΠ°Π°Ρ ΡΠΊΠ»ΠΎΠ½ΠΎΡΡ Π΄Π° ΡΠ΅ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½ΡΠ²Π°Π°Ρ Π²ΠΎ Π²ΠΈΠ΄ Π½Π° Π΅ΠΏΠΈΠ΄Π΅ΠΌΠΈΠΈ.
ΠΠ²ΠΈΠ΅ Π±ΠΎΠ»Π΅ΡΡΠΈ ΠΏΠΎΡΡΠΎΡΠ°Ρ ΠΎΡΠΊΠ°ΠΊΠΎ ΠΏΠΎΡΡΠΎΠΈ ΡΠΎΠ²Π΅ΡΡΠ²ΠΎΡΠΎ. ΠΠΈΠ² Π³ΠΈ ΡΠΏΠΎΠΌΠ½ΡΠ²Π°Π°Ρ ΠΈ Π½Π°ΡΡΡΠ°ΡΠΈΡΠ΅ Π΄ΠΎΠΊΡΠΎΡΠΈ: Π₯ΠΈΠΏΠΎΠΊΡΠ°Ρ, ΠΠ°Π»Π΅Π½, ΠΠ²ΠΈΡΠ΅Π½Π°. ΠΠΎ, Π·Π° Π½ΠΈΠ² ΠΏΠΎΠ²Π΅ΡΠ΅ ΡΠ΅ Π·Π½Π°Π΅ ΠΎΠ΄ ΠΏΠ΅ΡΠΈΠΎΠ΄ΠΎΡ Π½Π° XVI Π²Π΅ΠΊ ΠΈΠ»ΠΈ ΠΏΠΎΡΠΎΡΠ½ΠΎ ΠΎΠ΄ XVIII Π²Π΅ΠΊ ΠΊΠΎΠ³Π° Π΅ ΠΎΡΠΊΡΠΈΠ΅Π½ ΠΏΡΠΈΡΠΈΠΈΡΠ΅Π»ΠΎΡ Π½Π° ΡΡΠΌΠ°ΡΠ°. ΠΠΎ ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΡΠ΅ Π΄Π²Π° Π²Π΅ΠΊΠ° ΠΎΠ΄ Π²ΡΠΎΡΠΈΠΎΡ ΠΌΠΈΠ»Π΅Π½ΠΈΡΠΌ Π΄Π°ΡΠΈΡΠ°Π°Ρ ΠΈΠ½ΡΠ΅Π½Π·ΠΈΠ²Π½ΠΈ ΠΎΡΠΊΡΠΈΡΠΈΡΠ° Π½Π° ΠΏΡΠΈΡΠΈΠ½ΠΈΡΠ΅Π»ΠΈΡΠ΅ Π½Π° ΠΎΠ²ΠΈΠ΅ Π±ΠΎΠ»Π΅ΡΡΠΈ, Π° ΡΠΎ ΡΠΎΠ° ΡΠ΅ ΡΠΎΠ·Π΄Π°Π²Π°Π°Ρ ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π·Π° Π½ΠΈΠ²Π½ΠΎ ΠΏΡΠΎΡΡΡΠ²Π°ΡΠ΅, ΡΠΏΡΠ΅ΡΡΠ²Π°ΡΠ΅ ΠΈ Π»Π΅ΠΊΡΠ²Π°ΡΠ΅
- β¦